Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | CCR1 | P32246 | 2/20 | 0.30 |
| ▸ | CCR8 | P51685 | 2/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18904457 | 0.80 | CCR1 (0.44) | NPC1POLBRAB9AHSP90AA1CCR1 | |
| SCHEMBL18904499 | 0.80 | CCR1 (0.44) | MEN1KMT2ANPC1POLBOPRK1 | |
| SCHEMBL18904500 | 0.78 | CD74 (0.42) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL18904461 | 0.78 | CCR1 (0.40) | POLBHSP90AA1CCR1CCR8L3MBTL1 | |
| SCHEMBL18904464 | 0.73 | MEN1 (0.36) | MEN1KMT2ANPC1POLBOPRK1 | |
| SCHEMBL18904482 | 0.73 | TDP1 (0.39) | POLBHSP90AA1CCR1CCR8L3MBTL1 | |
| SCHEMBL13808799 | 0.71 | MEN1 (0.39) | MEN1KMT2ANPC1POLBOPRK1 | |
| SCHEMBL17231559 | 0.67 | L3MBTL1 (0.49) | NPC1POLBRAB9AHSP90AA1CCR1 | |
| SCHEMBL17343935 | 0.67 | CYP11B1 (0.49) | MEN1KMT2ANPC1POLBRAB9A | |
| SCHEMBL21518519 | 0.66 | CCR1 (0.45) | MEN1KMT2ANPC1HSP90AA1CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10177317-B2 | Organic light emitting display device | LG DISPLAY CO., LTD. (KR) | 2019-01-08 | — | — | US | disclosed |
| US-20170155055-A1 | ORGANIC LIGHT EMITTING DISPLAY DEVICE | LG DISPLAY CO., LTD. (KR) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10177317-B2 | Organic light emitting display device | OCIAD2, L1CAM, OCIAD1 | MEN1 3589/4885KMT2A 2759/4885NPC1 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.